? The effect of Colchicine in preventing post pericardiotomy syndrome

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N70

Enrollment

120

Registered

2018-03-02

Start date

2013-09-23

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post pericardiotomy syndrome. Pericarditis in diseases classified elsewhere

Interventions

Intervention 1: Intervention group: The case group received 1 milligram Colchicine twice a day after the first day of surgery, then 1 milligram daily for 1 month in patients with weight more than 70 k

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: age 18 years and more than open heart surgery indication

Exclusion criteria

Exclusion criteria: Contraindication for consumption Colchicine allergy to Colchicine pregnancy and breastfeeding

Design outcomes

Primary

Measure	Time frame
Atrial fibrillation. Timepoint: After cardiac surgery, discharge time, one month and six months later. Method of measurement: clinical examination, taking the electrocardiogram and, if necessary, electrocardiography.;Pericardial effusion. Timepoint: After cardiac surgery, discharge time, one month and six months later. Method of measurement: chest xray and Echocardiography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza rostami

Arak University of Medical Sciences

Rostami@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026